3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Prostatic Neoplasms
47
Glioblastoma
47
Breast Neoplasms
40
Esophageal Neoplasms
36
Rectal Neoplasms
35
Carcinoma, Non-Small-Cell Lung
34
Lung Neoplasms
33
Head and Neck Neoplasms
29
Squamous Cell Carcinoma of Head and Neck
26
Brain Neoplasms
23
Pancreatic Neoplasms
22
Neoplasms
19
Uterine Cervical Neoplasms
17
Oropharyngeal Neoplasms
16
Neoplasm Metastasis
16
Gliosarcoma
16
Esophageal Squamous Cell Carcinoma
16
Glioma
15
Sarcoma
14
Melanoma
14
Stomach Neoplasms
12
Adenocarcinoma Of Esophagus
12
Lymphoma, Follicular
9
Carcinoma, Squamous Cell
9
Mouth Neoplasms
8
Lymphoma, B-Cell, Marginal Zone
8
Anus Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Leukemia, Myeloid, Acute
7
Endometrial Neoplasms
7
Interventions
Cyclophosphamide
54
Tacrolimus
50
Methotrexate
36
Mycophenolic Acid
34
fludarabine phosphate
33
Busulfan
31
Cyclosporine
29
fludarabine
28
Antilymphocyte Serum
28
Melphalan
23
Sirolimus
21
Whole-Body Irradiation
18
Radiotherapy
18
Peripheral Blood Stem Cell Transplantation
18
Methylprednisolone
18
Filgrastim
15
thymoglobulin
13
Thiotepa
10
Stem Cell Transplantation
9
Rituximab
9
Granulocyte Colony-Stimulating Factor
8
Hematopoietic Stem Cell Transplantation
7
Etoposide
7
Cord Blood Stem Cell Transplantation
7
Cytarabine
6
Alemtuzumab
6
ruxolitinib
5
Transplantation
5
Therapeutics
5
Prednisone
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Graft vs Host Disease
×
Radiation
×
Clear all
NCT04678401
2025-10-20
IS-free Treg HaploHCT
Dana-Farber Cancer Institute
Phase 1
Recruiting
30 enrolled